We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boehringer Sues Five Generics Companies to Protect its Gilotrif Lung Cancer Therapy
Boehringer Sues Five Generics Companies to Protect its Gilotrif Lung Cancer Therapy
Over the past month, Boehringer Ingelheim has sued five manufacturers seeking to produce generic versions of the company’s Gilotrif lung cancer treatment — most recently naming Sandoz and Sun Pharmaceutical.